St. Vincents Hospital Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2018
NCT03671590
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

St Vincent's Hospital | St Vincents Hospital | St. Vincents Hospital

Active Ingredients

Drugs in Phase 4 Trials (2)

ezetimibe (zetia) (1 trial)

rosuvastatin (crestor) (1 trial)

Drugs in Phase 3 Trials (1)

human fecal microbiota (Reybota) (1 trial)

Drugs in Phase 1 Trials (3)

tg-1701 (1 trial)

ublituximab (Briumvi) (1 trial)

umbralisib (Ukoniq) (1 trial)

Drugs in Other Trials (2)

acetylsalicylic acid (aspirin) (1 trial)

clopidogrel (plavix) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 8